We also tested the hypothesis that the elevations in GFAP protein previously detected in brain parenchyma are also reflected at the level of CSF (cerebrospinal fluid), a site that is readily amenable to biopsy in human patients and in which increased GFAP has been observed in AxD patients (Kyllerman et al., 2005). The gene discussed is GFAP; the disease is Alexander disease.